JPWO2020018932A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020018932A5 JPWO2020018932A5 JP2021502769A JP2021502769A JPWO2020018932A5 JP WO2020018932 A5 JPWO2020018932 A5 JP WO2020018932A5 JP 2021502769 A JP2021502769 A JP 2021502769A JP 2021502769 A JP2021502769 A JP 2021502769A JP WO2020018932 A5 JPWO2020018932 A5 JP WO2020018932A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- soluble
- lifr
- amino acid
- soluble lifr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024098901A JP2024138287A (ja) | 2018-07-20 | 2024-06-19 | 可溶性ポリペプチド、および白血病抑制因子の活性を阻害するためのその使用方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862701399P | 2018-07-20 | 2018-07-20 | |
| US62/701,399 | 2018-07-20 | ||
| PCT/US2019/042648 WO2020018932A1 (en) | 2018-07-20 | 2019-07-19 | Soluble polypeptides and methods of using same for inhibiting leukemia inhibitory factor activity |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024098901A Division JP2024138287A (ja) | 2018-07-20 | 2024-06-19 | 可溶性ポリペプチド、および白血病抑制因子の活性を阻害するためのその使用方法 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021531002A JP2021531002A (ja) | 2021-11-18 |
| JPWO2020018932A5 true JPWO2020018932A5 (https=) | 2022-07-26 |
| JP2021531002A5 JP2021531002A5 (https=) | 2022-07-26 |
| JP7580800B2 JP7580800B2 (ja) | 2024-11-12 |
Family
ID=69164867
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021502769A Active JP7580800B2 (ja) | 2018-07-20 | 2019-07-19 | 可溶性ポリペプチド、および白血病抑制因子の活性を阻害するためのその使用方法 |
| JP2024098901A Pending JP2024138287A (ja) | 2018-07-20 | 2024-06-19 | 可溶性ポリペプチド、および白血病抑制因子の活性を阻害するためのその使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024098901A Pending JP2024138287A (ja) | 2018-07-20 | 2024-06-19 | 可溶性ポリペプチド、および白血病抑制因子の活性を阻害するためのその使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US12049490B2 (https=) |
| EP (1) | EP3823983A4 (https=) |
| JP (2) | JP7580800B2 (https=) |
| KR (1) | KR102917499B1 (https=) |
| CN (1) | CN112673017A (https=) |
| AU (1) | AU2019305086B2 (https=) |
| CA (1) | CA3106679A1 (https=) |
| WO (1) | WO2020018932A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026006563A1 (en) * | 2024-06-27 | 2026-01-02 | Nvasc, Inc. | Long-lasting lif proteins and formulations |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2097291A1 (en) * | 1990-12-13 | 1992-06-14 | David P. Gearing | Leukemia inhibitory factor receptors |
| US5262522A (en) * | 1991-11-22 | 1993-11-16 | Immunex Corporation | Receptor for oncostatin M and leukemia inhibitory factor |
| CA2139504A1 (en) * | 1992-07-01 | 1994-01-20 | Nicos A. Nicola | Leukaemia inhibitory factor-binding protein |
| AUPO632897A0 (en) * | 1997-04-21 | 1997-05-15 | Walter And Eliza Hall Institute Of Medical Research, The | Novel chimeric molecules |
| EP1878745B1 (en) * | 2005-04-22 | 2011-06-15 | Keio University | Humanin receptor or humanin-like polypeptide receptor |
| KR101235820B1 (ko) * | 2012-02-17 | 2013-02-21 | 한국생명공학연구원 | 항암 표적치료제제 감수성 예측용 ｓｎｐ |
| GB2552473A (en) * | 2016-07-21 | 2018-01-31 | Evox Therapeutics Ltd | Surface decoration of extracellular vesicles |
| WO2018029586A1 (en) * | 2016-08-07 | 2018-02-15 | Novartis Ag | Mrna-mediated immunization methods |
-
2019
- 2019-07-19 CA CA3106679A patent/CA3106679A1/en active Pending
- 2019-07-19 AU AU2019305086A patent/AU2019305086B2/en active Active
- 2019-07-19 JP JP2021502769A patent/JP7580800B2/ja active Active
- 2019-07-19 US US17/260,473 patent/US12049490B2/en active Active
- 2019-07-19 KR KR1020217004873A patent/KR102917499B1/ko active Active
- 2019-07-19 WO PCT/US2019/042648 patent/WO2020018932A1/en not_active Ceased
- 2019-07-19 CN CN201980058852.7A patent/CN112673017A/zh active Pending
- 2019-07-19 EP EP19838531.2A patent/EP3823983A4/en active Pending
-
2024
- 2024-06-19 JP JP2024098901A patent/JP2024138287A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025063029A5 (https=) | ||
| Zdanov | Structural features of the interleukin-10 family of cytokines | |
| JP2021522175A5 (https=) | ||
| IL308851B1 (en) | T cell modulatory multimeric polypeptides and methods of using them | |
| JP2023103368A5 (https=) | ||
| CN102238965A (zh) | 选择性抗癌嵌合肽 | |
| JPWO2020063488A5 (https=) | ||
| WO2009142773A4 (en) | Multivalent fibronectin based scaffold domain proteins | |
| JP2023036899A5 (https=) | ||
| NO20025153D0 (no) | FremgangsmÕter og sammensetninger for Õ svekke formering av HIV-1 | |
| JP2021531834A5 (https=) | ||
| KR20130037218A (ko) | 신규 jnk 억제제 분자 | |
| JP2018535972A5 (https=) | ||
| CA2386471A1 (en) | Purification of recombinant proteins fused to multiple epitopes | |
| CN100577686C (zh) | 寡聚肽及其治疗hiv感染的用途 | |
| Wiesmann et al. | Ligand-binding sites in Ig-like domains of receptor tyrosine kinases | |
| JP2021531002A5 (https=) | ||
| JPWO2020018932A5 (https=) | ||
| JP2008510468A5 (https=) | ||
| JPWO2020257191A5 (https=) | ||
| JP2019518713A5 (https=) | ||
| JP2022502078A5 (https=) | ||
| WO1994029332A1 (en) | Coiled-coil stem loop templates | |
| JPH04505019A (ja) | ガンマインターフェロンのポリペプチド性阻害剤 | |
| JP2019536802A5 (https=) |